Deletion of Eed destabilizes PRC2 (192), and deletion of Eed or Ezh2 in SHH-MB models is sufficient to promote the expression of genes typically suppressed by PRC2, specifically promoting myeloid differentiation and tumor progression (192). The gene discussed is EED; the disease is neoplasm.